Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

21.82
+0.56002.63%
Post-market: 22.090.2685+1.23%19:41 EDT
Volume:1.42M
Turnover:31.26M
Market Cap:4.24B
PE:-43.57
High:22.37
Open:21.44
Low:21.38
Close:21.26
52wk High:37.50
52wk Low:16.24
Shares:194.49M
Float Shares:90.19M
Volume Ratio:0.58
T/O Rate:1.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5008
EPS(LYR):-1.6200
ROE:-8.08%
ROA:-1.92%
PB:3.45
PE(LYR):-13.47

Loading ...

Legend Biotech Interim CEO Alan Bash Files Initial Beneficial Ownership Statement

Reuters
·
Aug 04

Legend Biotech (LEGN) CEO Exit Raises Questions, Is The Stock Still Cheap?

Simply Wall St.
·
Jul 31

Legend Biotech to Host Investor Call on Second-quarter 2026 Results

Reuters
·
Jul 28

Legend Biotech Corp : Raymond James Cuts Target Price to $58 from $86

THOMSON REUTERS
·
Jul 28

Legend Biotech Price Target Maintained with a $65.00/Share by HC Wainwright & Co.

Dow Jones
·
Jul 28

Buy Rating Reiterated as Strong CARVYKTI Momentum and Attractive Valuation Support Unchanged $65 Price Target

TIPRANKS
·
Jul 28

Under the Radar: Legend Stock Tumbles After CEO's Abrupt Departure

Dow Jones
·
Jul 28

Legend Biotech's In Vivo CAR-T Cell Therapy Data Validates Approach, RBC Capital Markets Says

MT Newswires Live
·
Jul 27

Legend Biotech is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 27

Legend Biotech falls -12.5%

TIPRANKS
·
Jul 27

Legend Biotech price target lowered to $59 from $63 at RBC Capital

TIPRANKS
·
Jul 27

RBC Cuts Price Target on Legend Biotech to $59 From $63, Keeps Outperform Rating

MT Newswires Live
·
Jul 27

Legend Biotech Shares Down 3.7% Premarket; Ying Huang Steps Down as CEO and Board Member, Alan Bash Appointed Interim CEO

THOMSON REUTERS
·
Jul 27

Legend Biotech Names Alan Bash Interim CEO After Ying Huang Resigns

Reuters
·
Jul 27

Legend Biotech Corp - Ying Huang Steps Down as CEO and Board Member; to Remain as Advisor Through August

THOMSON REUTERS
·
Jul 27

Legend Biotech Corp - Alan Bash Appointed Interim CEO

THOMSON REUTERS
·
Jul 27

Legend Biotech Corp - Board Initiates Search for Permanent CEO Successor

THOMSON REUTERS
·
Jul 27

Legend Biotech Announces CEO Transition

THOMSON REUTERS
·
Jul 27

Legend Biotech Shares Fall After UBS Downgrade

MT Newswires Live
·
Jul 25

Legend Biotech Cut to Neutral from Buy by UBS

Dow Jones
·
Jul 24